Skip to content
2000
Volume 17, Issue 2
  • ISSN: 2667-3878
  • E-ISSN: 2667-3886

Abstract

Over the last few decades, hot melt extrusion (HME) has found extensive adaptability and utility as a viable drug delivery option in the pharmaceutical industry. HME has already been validated as a robust, novel technique mainly used for the correction of solubility and bioavailability of poorly soluble drugs. In line with the scope of the current issue, this review appraises the value of HME as a means of solubility enhancement of BCS class II drugs and presents an influential tool for the manufacturing or production of drugs or chemicals. The drug development process can be shortened with the use of hot melt extrusion technology, and the application of this process to analytical technology can ease the manufacturing process. This review focuses on the tooling, utility, and manufacturing aspects associated with hot melt extrusion technology.

Loading

Article metrics loading...

/content/journals/raddf/10.2174/2667387817666230425135344
2023-06-01
2025-05-30
Loading full text...

Full text loading...

/content/journals/raddf/10.2174/2667387817666230425135344
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test